531592 — Genpharmasec Balance Sheet
0.000.00%
- IN₹592.48m
- IN₹825.33m
- IN₹1.40bn
Annual balance sheet for Genpharmasec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 40.6 | 29.5 | 205 | 52.8 | 110 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 75.4 | 62.4 | 115 | 136 | 295 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 215 | 189 | 410 | 273 | 805 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.04 | 1 | 8.39 | 75.8 | 231 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 217 | 199 | 711 | 799 | 1,382 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 62.8 | 20.6 | 27 | 98.4 | 470 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 62.8 | 45.4 | 67.3 | 147 | 719 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 154 | 153 | 644 | 652 | 663 |
| Total Liabilities & Shareholders' Equity | 217 | 199 | 711 | 799 | 1,382 |
| Total Common Shares Outstanding |